What's The US Medicare Deal & How Will It Impact Pharma Companies? I Nimish Mehta On Pharma Stocks

The Biden administration's plan to cap Medicare patient costs for generic drugs at $2 monthly has negatively impacted Indian pharma stocks like Lupin and Sun Pharma. Although the policy will only be implemented by 2027 and initially affects around 150 drugs, there are concerns over long-term pricing pressures.
#pharma #pharmastocks #pharmacompany